02:31:01 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



Ventripoint Diagnostics Ltd (2)
Symbol VPT
Shares Issued 156,823,905
Close 2023-12-11 C$ 0.255
Market Cap C$ 39,990,096
Recent Sedar Documents

Ventripoint to distribute in NA hospitals via A SCEND

2023-12-12 11:43 ET - News Release

Mr. Jonathan Robinson reports

ASCEND CARDIOVASCULAR TO MARKET AND DISTRIBUTE VENTRIPOINT'S AI-POWERED HEART-SCANNING TECHNOLOGY TO NORTH AMERICAN HOSPITALS AND CLINICS

Ventripoint Diagnostics Ltd. has entered into a global distribution and marketing agreement with A SCEND Cardiovascular.

A SCEND Cardiovascular is a leader in offering cutting-edge diagnostic, and imaging technologies and workflows to improve cardiac health care. A SCEND is trusted by AGFA Healthcare, Sectra, Oracle/ Cerner, and other major players in the healthcare system. Its technology stack has been integrated into the workflows of 1,000+ top-ranked healthcare facilities and 600+ health systems, representing a user base of 50,000 who serve millions of heart patients.

A SCEND will market and distribute Ventripoint's AI-powered heart-scanning technology, which turns ultrasound images of the heart into MRI-quality heart images. Using AI, and the images from existing ultrasound systems of any brand, Ventripoint creates these MRI-quality heart images at a fraction of the cost and time needed for more traditional heart MRIs. " After many years of careful research and development, and rigorous in-hospital testing, Ventripoint's heart-imaging technology with A SCEND 's proven support is ready for the world's hospitals and he a rt patients ," said Dr. Alvira Macanovic, President & CEO of Ventripoint. " With this A SCEND partnership I am encouraged we will win the confidence of hospitals and cardiologists across North America and beyond ."

" We are looking forward to the partnership between Ventripoint Diagnostics and A SCEND Cardiovascular. Our aim is that by working together, we can ultimately provide reliable and effective tools for clinicians on a global scale ," stated Jeffrey Soble, MD, ASCEND's President and CEO. The global distribution agreement has an initial two-year term, with ASCEND as the official reseller. A SCEND will market and sell the Ventripoint VMS+ system as part of its inclusive solution, as well as integration with A SCEND 's cardiovascular IT platform. Ventripoint will be providing support and training to ASCEND on the use and capabilities of the VMS+ during the term of the agreement. The collaboration between Ventripoint and ASCEND will reduce time to market and overall effort to provide new software solutions to the market.

" Combining these two products creates an end-to-end solution rivaling the best technology offered on the market , said Dr. Macanovic. " Our partnership includes joint research and development initiatives to optimize current technologies and exploratory projects to identify new treatment possibilities, reduce waiting times, and ensure a cost-effective addition to the heart healthcare system ."

Ventripoint, now commercializing its technology, has won accolades from leading hospitals, and the British Heart Foundation and has drawn international media attention . As the relationship between Ventripoint and ASCEND Cardiovascular continues to evolve, both companies remain committed to driving innovation and excellence in cardiovascular health technology.

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary KBR technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe, and Canada. Learn more: www.ventripoint.com .

About ASCEND Cardiovascular

ASCEND Cardiovascular is a leader in innovating cardiovascular solutions that empower the provider community to improve cardiovascular care. Designed with openness in mind, our solutions integrate with EHRs, medical devices, and other systems to deliver seamless workflows that span procedure types and modalities. A complete cardiovascular solution, ASCEND provides structured reporting, image visualization, collaboration, and analytics that improve efficiency, outcomes, and ROI. With decades of experience and a practicing cardiologist at our helm, the ASCEND team brings unparalleled "know how" in cardiology workflow, collaboration, and IT offering limitless opportunities to improve clinical, operational, and quality performance. Learn more: www.ascendcv.com .

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.